Strategic Advocates’s QuidelOrtho QDEL Stock Holding History

Strategic Advocates’s Portfolio QDEL Stock Details QDEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-2	Closed	-$59	–	521
2025 Q4	$59	Hold	2	–	–	﹤0.01%	607
2025 Q3	$59	Buy	+2	New	+$55	﹤0.01%	588

Other funds holding QDEL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Strategic Advocates's QDEL Position: Q1 2026 in Review

Strategic Advocates sold out of QuidelOrtho (QDEL) in Q1 2026, closing a stake of 2 shares — an estimated $59 sold.

Strategic Advocates first reported a position in QDEL in Q3 2025 and held it in 2 quarters. The position peaked at $59 in Q4 2025. 239 funds tracked by Wall St. Rank hold QDEL as of Q1 2026.

Strategic Advocates reported no remaining QuidelOrtho position as of Q1 2026 after selling out during the quarter.
Strategic Advocates sold 2 QuidelOrtho shares in Q1 2026, an estimated $59.
Strategic Advocates first reported a position in QuidelOrtho in Q3 2025 and held it in 2 quarters.
Strategic Advocates's QuidelOrtho position peaked at $59 in Q4 2025.
239 funds tracked by Wall St. Rank held QuidelOrtho as of Q1 2026.

Based on Strategic Advocates's 13F filing for Q1 2026, filed 15 May 2026.